Novian Health Receives FDA Approval to Study Breast Cancer Therapy July 14, 2011 08:15 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser […]
Archives for July 2011
